Council of Scientific and Industrial Research

Prabhat Ranjan Mishra

Ritu Trivedi

Avinash Kumar

Srikanta Kumar Rath

Sulekha Adhikary

Naresh Mittapelly

Dharmendra Choudhary

Sudhir Kumar

Brijesh Kumar

Rakesh Maurya

Anil Kumar Dwivedi

Rajender Singh Sangwan

Naibedya Chattopadhyay

Neelam Singh Sangwan

Sabyasachi Sanyal

Varsha Gupta

Arun Kumar Trivedi

Divya Singh

Anagha Gurjar

Jyoti Gautam

Riyazuddin Mohammed

Kamal Ram Arya

Vikram Khedgikar

Jiaur Rahaman Gayen

Girish Kumar Gupta

Kamini Srivastava

Ramakrishna Eppalapally

Priyanka Kushwaha

Subhashis Pal

Padam Kumar

Anirudha Karvande

Ashwni Verma

Shweta Sharma

Sapana

Maurya Rakesh

Prabodh K Trivedi

Naibedya Chattopadhayay

Naseer Ahmad

Kapil Dev

The present invention relates to a bioactive extract, fraction ofand formulation thereof for bone regeneration and treatment of glucocorticoid induced musculo-skeletal diseases and associated electrolyte imbalances.

Bioactive extract, fraction ofand formulation thereof for bone regeneration

A method for prevention and/or treatment of diminution of bone tissue using a composition comprising a compound selected from Withaferin A (WFA), Withanolide A, and Withanone. The composition showed enhanced WFA bioavailability in rodents against plain WFA, promotes bone marrow cell differentiation, and increases the percent of bone volume to tissue volume (BV/TV %) by 3 folds as compared to free Withaferin A (WFA).

Pharmaceutical composition for the treatment of diminution of bone tissue

The present invention relates to a formulation ofuseful for the prevention or treatment of osteo-health related disorders. The present invention relates to the field of pharmaceutical formulation that provides extract, fractions, pure compound isolated from natural sources and formulation thereof useful for the prevention and treatment of various medical indications. Further, this invention relates to conditions associated with estrogen dependent or independent diseases (primary/secondary osteoporosis) or syndromes or disorders preferably relating to cartilage such as osteoarthritis caused in humans and animals. Furthermore, this invention relates to achievement of peak bone mass during skeletal growth and health in humans and animals. Particularly, the present invention relates to the processes for the preparation of biologically active extracts, fromfrom the family Amaranthaceae their pharmaceutically acceptable excepients and compositions of the principal aspect of the present invention.

Formulation for the prevention and treatment of bone related disorders

The present invention relates to a microcapsule for controlled release of flavanoid compound and a process for preparation thereof. The microcapsule comprising a core particle consisting of a calcium salt, Pluronic F68 [poly (ethylene oxide-co-polypropylene oxide), block poly oxyethylene-polypropylene block copolymer], loaded with a flavanoid compound, the resulting core particle having a plurality of alternate layers of cationic and anionic polyelectrolytes adsorbed thereon and an outer layer formed by a bile salt, wherein the flavanoid is ranging between 10 to 96% by weight.

Controlled release micro-capsule for osteogenic action

Growing community of inventors

Uttar Pradesh, India

Prabhat Ranjan Mishra